Join Lee Goddard and Jin Shen as they share Montefiore Medical Center’s Department of Radiation Oncology’s initial experience of the VOLO™ Ultra Optimizer for the Radixact® System. Montefiore Medical Center’s Department of Radiation Oncology strives to develop and incorporate the newest technologies and methods available to combat the progress of cancer and outstanding radiation oncology care is crucial for many of their patients with the disease. Since installing the Radixact System at the Moses campus in 2017, Montefiore has been an early adopter of both Synchrony® and ClearRT™ for the Radixact System. The utilization of VOLO Ultra Optimizer for treatment planning has allowed them to ensure the best plans are created and delivered to patients. This webinar will present Montefiore Medical Center’s initial experience with VOLO Ultra.
Dr. Lane Rosen at Willis-Knighton Cancer Center will share his insights and clinical experience of using ClearRT™, Accuray fully integrated, diagnostic-like fan-beam kVCT imaging for the Radixact® System.
MyAccuray: VOLO™ Ultra, a New Way of Planning with Accuray Precision® Treatment Planning System, Architected to Accelerate Radixact® and TomoTherapy® Treatments
This year at ESTRO, Accuray is unveiling the latest in our leading legacy of innovation that empowers clinicians to deliver more, better, faster: VOLO Ultra. Kai Schubert will share his preliminary insights with the simplicity of planning, excellent plan quality and transformative speed for TomoTherapy® System treatments.
Delivering effective and safe lung cancer stereotactic body radiation therapy (SBRT) requires technology that can account for lung tumor motion. Both fiducial-based and markerless tracking algorithms currently exist, with markerless being a focus of innovation, investment and research in the field. These tracking algorithms, however, have not been benchmarked using a common, prospective measurement methodology. The American Association of Physicists in Medicine (AAPM) designed the MArkerless Lung Target Tracking CHallenge (MATCH), an AAPM Grand Challenge, to compare the precision and accuracy of existing markerless tracking algorithms.
Shawn Prince, MBA is the Senior Director, Patient Access at Accuray Incorporated.